Product Information
NY2267 is an inhibitor of protein kinases that has shown promise in the treatment of tumors. It works by inducing apoptosis, or programmed cell death, in cancer cells. NY2267 is an analog of nintedanib, a drug used to treat idiopathic pulmonary fibrosis. Studies have shown that NY2267 inhibits the growth of various types of cancer cells, including those from Chinese hamster ovaries and human urine. This potent anticancer agent targets multiple kinases involved in tumor growth and development, making it a promising candidate for cancer therapy.
Chemical properties
Technical inquiry about: 3D-LKB05373 NY2267
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
